肺癌术后并发急性重型丙型肝炎1例报告

李孝锋; 赵燕燕; 孙永涛; 康文

doi:10.3969/j.issn.1001-5256.2021.05.037

肺癌术后并发急性重型丙型肝炎1例报告

DOI: 10.3969/j.issn.1001-5256.2021.05.037

空军军医大学唐都医院传染病科，西安 710038

基金项目:

十三五国家科技重大专项 (2017ZX10202101-003-007)

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：李孝锋参与疾病的诊断和治疗，负责资料收集、论文撰写和论文修改；赵燕燕、孙永涛、康文参与疾病的诊断和治疗，指导论文撰写并最后定稿。

详细信息

作者简介:
李孝锋(1983—)，男，主治医师，主要从事病毒学肝炎临床研究

通信作者:
康文, 82399536@qq.com

中图分类号: R512.63
计量
- 文章访问数: 408
- HTML全文浏览量: 170
- PDF下载量: 23
- 被引次数: 0
出版历程
- 收稿日期: 2020-10-30
- 录用日期: 2020-12-15
- 出版日期: 2021-05-20

Acute severe hepatitis C after surgery for lung cancer: A case report

Department of Infectious Diseases, Tangdu Hospital, Air Force Medical University of PLA, Xi'an 710038, China

摘要

- 丙型肝炎 /
- 丙型肝炎抗体 /
- 诊断 /
- 治疗学
- Hepatitis C /
- Hepatitis C Antibodies /
- Diagnosis /
- Therapeutics

HTML全文

参考文献(11)

[1]	SPEARMAN CW, DUSHEIKO GM, HELLARD M, et al. Hepatitis C[J]. Lancet, 2019, 394(10207): 1451-1466. DOI: 10.1016/S0140-6736(19)32320-7.
[2]	MARTINELLO M, HAJARIZADEH B, GREBELY J, et al. Management of acute HCV infection in the era of direct-acting antiviral therapy[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(7): 412-424. DOI: 10.1038/s41575-018-0026-5.
[3]	LINGALA S, GHANY MG. Natural history of hepatitis C[J]. Gastroenterol Clin North Am, 2015, 44(4): 717-734. DOI: 10.1016/j.gtc.2015.07.003.
[4]	SAGNELLI E, SANTANTONIO T, COPPOLA N, et al. Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment[J]. Infection, 2014, 42(4): 601-610. DOI: 10.1007/s15010-014-0608-2.
[5]	LOOMBA R, RIVERA MM, MCBURNEY R, et al. The natural history of acute hepatitis C: Clinical presentation, laboratory findings and treatment outcomes[J]. Aliment Pharmacol Ther, 2011, 33(5): 559-565. DOI: 10.1111/j.1365-2036.2010.04549.x.
[6]	COX AL, NETSKI DM, MOSBRUGER T, et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection[J]. Clin Infect Dis, 2005, 40(7): 951-958. DOI: 10.1086/428578.
[7]	Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for hepatitis C (2019 version)[J]. J Clin Hepatol, 2019, 35(12): 2670-2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008. 中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2670-2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008.
[8]	GALLI C, JULICHER P, PLEBANI M. HCV core antigen comes of age: A new opportunity for the diagnosis of hepatitis C virus infection[J]. Clin Chem Lab Med, 2018, 56(6): 880-888. DOI: 10.1515/cclm-2017-0754.
[9]	ZHANG YQ, WANG J, CHANG JX, et al. Correlation and the clinical significance of hepatitis C virus RNA and hepatitis C core antigen[J/CD]. Chin J Exp Clin Infect Dis: Electronic Edition, 2019, 13(3): 185-189. DOI: 10.3877//cma.j.issn.1674-1358.2019.03.003. 张怡青, 王洁, 常静霞, 等. 丙型肝炎病毒RNA与核心抗原的相关性及其临床意义[J/CD]. 中华实验和临床感染病杂志(电子版), 2019, 13(3): 185-189. DOI: 10.3877//cma.j.issn.1674-1358.2019.03.003.
[10]	CHEVALIEZ S, FELD J, CHENG K, et al. Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen[J]. Antivir Ther, 2018, 23(3): 211-217. DOI: 10.3851/IMP3042.
[11]	GHANY MG, MORGAN TR, AASLD-IDSA Hepatitis C guidance panel. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection[J]. Hepatology, 2020, 71(2): 686-721. DOI: 10.1002/hep.31060.